AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Miao, H Wei, BR Peehl, DM Li, Q Alexandrou, T Schelling, JR Rhim, JS Sedor, JR Burnett, E Wang, BC
Citation: H. Miao et al., Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway, NAT CELL BI, 3(5), 2001, pp. 527-530

Authors: Covic, AMC Iyengar, SK Olson, JM Sehgal, AR Constantiner, M Jedrey, C Kara, M Sabbagh, E Sedor, JR Schelling, JR
Citation: Amc. Covic et al., A family-based strategy to identify genes for diabetic nephropathy, AM J KIDNEY, 37(3), 2001, pp. 638-647

Authors: Kane, SL Constantiner, M Staubus, AE Meinecke, CD Sedor, JR
Citation: Sl. Kane et al., High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose, ANN PHARMAC, 34(10), 2000, pp. 1146-1151

Authors: Zarif, L Covic, A Iyengar, S Sehgal, AR Sedor, JR Schelling, JR
Citation: L. Zarif et al., Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis, NEPH DIAL T, 15(11), 2000, pp. 1801-1807

Authors: El-Meanawy, MA Schelling, JR Pozuelo, F Churpek, MM Ficker, EK Iyengar, S Sedor, JR
Citation: Ma. El-meanawy et al., Use of serial analysis of gene expression to generate kidney expression libraries, AM J P-REN, 279(2), 2000, pp. F383-F392

Authors: Covic, AMC Schelling, JR Constantiner, M Iyengar, SK Sedor, JR
Citation: Amc. Covic et al., Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients, KIDNEY INT, 58(4), 2000, pp. 1742-1750

Authors: Schelling, JR Zarif, L Sehgal, A Iyengar, S Sedor, JR
Citation: Jr. Schelling et al., Genetic susceptibility to end-stage renal disease, CURR OP NEP, 8(4), 1999, pp. 465-472

Authors: Huang, SM Konieczkowski, M Schelling, JR Sedor, JR
Citation: Sm. Huang et al., Interleukin-1 stimulates Jun N-terminal/stress-activated protein kinase byan arachidonate-dependent mechanism in mesangial cells, KIDNEY INT, 55(5), 1999, pp. 1740-1749

Authors: Singh, R Wang, B Shirvaikar, A Khan, S Kamat, S Schelling, JR Konieczkowski, M Sedor, JR
Citation: R. Singh et al., The IL-1 receptor and Rho directly associate to drive cell activation in inflammation, J CLIN INV, 103(11), 1999, pp. 1561-1570
Risultati: 1-9 |